Table of Contents
- 1 Liver cancers: radioembolization launched in Saint-Philibert
- 2 Improve patient survival, without degrading their quality of life
- 3 **How will the implementation of radioembolization potentially impact the long-term prognosis and quality of life for liver cancer patients in the Hauts-de-France region? **
Par
Nicolas Demollien
Published on Nov. 22, 2024 at 6:42 p.m.
This is an important announcement for theSaint-Philibert hospital de Lomme, and all patients with liver cancer. THE Group of Hospitals of the Catholic Institute de Lille (GHICL) announces the launch of the radioembolisationa medical technology against this disease. Valuable for patients suffering from inoperable liver tumors, it allows, thanks to a very targeted method, “to treat tumors preciselywith a limited impact on healthy cells.”
Liver cancers: radioembolization launched in Saint-Philibert
Practiced since September 2024, this method was made possible thanks to the new care pathway launched by the hospital in 2023. “This integrates new cutting-edge technologies and the operation of a hybrid and versatile operating theater, including a state-of-the-art interventional radiology room combining a scanner and an angiography room,” the establishment explains.
Radioembolization, also known as transarterial radioembolization (TARE) or radioactive microsphere treatment, is a medical technique used primarily to treat liver cancers, including hepatocellular carcinomas, cholangiocarcinoma, and liver metastases from colorectal cancer.
This technique consists of injecting radioactive microspheres in a very targeted manner into the arteries of the liver which supply the tumors. These microspheres release targeted radiation directly on the tumor cells, destroying them while sparing the surrounding healthy liver tissue.
Improve patient survival, without degrading their quality of life
Performed under local anesthesia, radioembolization is intended for non-operable patients with a localized tumor on part of the liver. This method can be offered as an alternative or in addition to chemotherapy.
Radioembolization is a continuation of the launch of the new operating theater which emerged on the occasion of the extension of the Saint Philibert hospital. The new building in question, with its interventional radiology room, aims to accommodate operating and interventional activities and has 16 intervention rooms including 4 hybrid rooms. One of them is equipped with a surgical robot.
“The launch of this operating theater with the hybrid interventional radiology room was a decisive element in considering this new method of radioembolization. Regarding a multidisciplinary treatmentit in fact calls on different advanced technologiesand with several trades involved. Oncologists, gastrologists, interventional radiology, nuclear medicine, radiopharmacists, and even digestive and hepatic surgeons… We are fortunate to be able to count on seasoned teams and thus have all the necessary skills,” assures Mustapha Azahaf. , practitioner and head of the radiology department at Saint Vincent de Paul hospital.
Transarterial radioembolization (TARE) thus illustrates the synergy between interventional radiology, nuclear medicine and radiopharmacy. It has been offered for more than 10 years in major university hospitals in France. In the Hauts-de-France region, Saint Philibert hospital is the 3rd establishment to offer this treatment method.
More information on the site saintphilibert-lomme.fr
Follow all the news from your favorite cities and media by subscribing to Mon Actu.
**How will the implementation of radioembolization potentially impact the long-term prognosis and quality of life for liver cancer patients in the Hauts-de-France region? **
## Interview: Radioembolization at Saint-Philibert Hospital – A New Hope for Liver Cancer Patients
**Introduction**
Welcome to World Today News, where we bring you the latest advancements in healthcare. Today, we’re joined by two esteemed guests to discuss the groundbreaking news from Saint-Philibert hospital in Lomme, France. We’re delighted to welcome Dr. [Guest 1 name], a leading oncologist specializing in liver cancer, and Mr. [Guest 2 name], Director of the Radiology Department at Saint-Philibert.
**Section 1: Understanding Radioembolization**
* **Dr. [Guest 1 name], can you explain in simple terms what radioembolization is and how it works for patients with liver cancer?**
* **Mr. [Guest 2 name], what makes radioembolization unique compared to other liver cancer treatments like chemotherapy or surgery, and could you elaborate on the specific technology involved in this procedure at Saint-Philibert?**
* **Dr. [Guest 1 name], what types of liver cancer patients are most likely to benefit from radioembolization, and are there any potential limitations or risks associated with this procedure?**
**Section 2: The Saint-Philibert Initiative**
* **Mr. [Guest 2 name], what inspired Saint-Philibert hospital to introduce radioembolization, and what were the key factors that made this new treatment modality possible?**
* **Dr. [Guest 1 name], how significant is this development for liver cancer patients in the Hauts-de-France region, and how will radioembolization contribute to improving their quality of life and survival rates?**
* **Mr. [Guest 2 name], the article mentions a new operating theatre and advanced technologies. Can you elaborate on how these investments directly facilitated the implementation of radioembolization?**
**Section 3: Collaborative Care and Future Outlook**
* **Dr. [Guest 1 name], what role does a multidisciplinary team play in the successful implementation of radioembolization, and how important is close collaboration between oncologists, radiologists, surgeons, and other specialists in treating liver cancer?**
* **Mr. [Guest 2 name], where do you see the future of radioembolization at Saint-Philibert hospital? Are there plans for further research or development in this field?**
* **Dr. [Guest 1 name], what message would you give to liver cancer patients who are exploring their treatment options and considering radioembolization?**
**Conclusion**
Thank you both for sharing your valuable insights and expertise. The introduction of radioembolization at Saint-Philibert hospital marks a significant milestone for liver cancer patients in the region. We commend the dedication and collaboration of the medical team at Saint-Philibert in bringing this innovative treatment option to those who need it most. We hope this conversation provides our viewers with a better understanding of radioembolization and its potential to improve the lives of millions affected by liver cancer
